Nuveen Asset Management, LLC Talaris Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$4.51 - $9.85 $90,200 - $197,000
20,000 Added 48.17%
61,523 $277,000
Q4 2021

Feb 14, 2022
BUY
$12.18 - $17.0 $222,626 - $310,726
18,278 Added 78.63%
41,523 $589,000
Q3 2021

Nov 12, 2021
BUY
$11.61 - $15.99 $106,196 - $146,260
9,147 Added 64.88%
23,245 $328,000
Q2 2021

Aug 16, 2021
BUY
$12.25 - $18.61 $172,700 - $262,363
14,098 New
14,098 $207,000

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email